1. Raschi E, Salvo F, Khouri C. Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to action. Br J Clin Pharmacol. 2022 Jul;88(7):3535-3536.
2. Khouri C, Revol B, Lepelley M, Mouffak A, Bernardeau C, Salvo F, Pariente A, Roustit M, Cracowski JL. A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases. J Clin Epidemiol. 2021 Nov;139:191-198. doi: 10.1016/j.jclinepi.2021.07.014. Epub 2021 Jul 27. PMID: 34329725.
3. Mouffak A, Lepelley M, Revol B, Bernardeau C, Salvo F, Pariente A, Roustit M, Cracowski JL, Khouri C. High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study. J Clin Epidemiol. 2021 Oct;138:73-79. doi: 10.1016/j.jclinepi.2021.06.022. Epub 2021 Jun 26. PMID: 34186195.
4. Raschi, E. , Moretti, U. , Salvo, F. , Pariente, A. , Antonazzo, I. C. , De Ponti, F. , Poluzzi, E. . Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety. In: Kothari, C. S. , Shah, M. , Patel, R. M. , editors. Pharmacovigilance [Internet]. London: IntechOpen; 2018 [cited 2022 Jul 05]. Available from: https://www.intechopen.com/chapters/63595 doi: 10.5772/intechopen.79986
5. Raschi E, Poluzzi E, Salvo F, Pariente A, De Ponti F, Marchesini G, Moretti U. Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems. Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):533-542. doi: 10.1016/j.numecd.2018.02.014. Epub 2018 Mar 1. PMID: 29625780.
6. Khouri C, Fusaroli M, Salvo F, Raschi E. Interpretation of Pharmacovigilance Disproportionality Analyses. Clin Pharmacol Ther. 2023 May 30. doi: 10.1002/cpt.2951. Epub ahead of print. PMID: 37248829.
7. Cortes B, Jambon-Barbara C, Cracowski JL, Khouri C. Validity, relevance and interpretation of pharmacovigilance disproportionality analyses. Bone. 2023 May;170:116685. doi: 10.1016/j.bone.2023.116685. Epub 2023 Feb 8. PMID: 36764505.
8. Khouri C, Fusaroli M, Salvo F, Raschi E. Transparency and robustness of safety signals. BMJ. 2022 Nov 3;379:o2588. doi: 10.1136/bmj.o2588. PMID: 36328354.
9. Raschi E, Schoretsanitis G, Gastaldon C, Khouri C, Salvo F, De Ponti F. Antipsychotics and Drug-Induced Liver Injury: Toward Minimum Requirements in Reporting Pharmacovigilance Studies. J Clin Psychopharmacol. 2023 Jan-Feb 01;43(1):81-83. doi: 10.1097/JCP.0000000000001647. PMID: 36584260.